Intragraft IL-4 mRNA expression is associated with down-regulation of liver graft rejection

Clinical Transplantation

Volumn 10, Issue 6 I, 1996, Pages 542-549

  Baan, C C ^a   Metselaar, H J ^a   Mol, W M ^a   Tilanus, H W ^a   Ijzermans, J M N ^a   Zondervan, P E ^a   Schalm, S W ^a   Niesters, H G M ^a   Weimar, W ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

IL 4; Liver graft rejection; mRNA

Indexed keywords

ASPARTATE AMINOTRANSFERASE; BILIRUBIN; INTERLEUKIN 2; INTERLEUKIN 4; MESSENGER RNA;

ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILIRUBIN BLOOD LEVEL; CLINICAL ARTICLE; FEMALE; GRAFT REJECTION; HELPER CELL; HUMAN; HUMAN TISSUE; LIVER TRANSPLANTATION; MALE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ASPARTATE AMINOTRANSFERASES; BILIRUBIN; BIOPSY; BLOTTING, SOUTHERN; DOWN-REGULATION; FEMALE; GENE EXPRESSION REGULATION; GRAFT REJECTION; HUMANS; IMMUNITY, CELLULAR; INTERLEUKIN-2; INTERLEUKIN-4; LIVER TRANSPLANTATION; MALE; POLYMERASE CHAIN REACTION; REMISSION, SPONTANEOUS; RNA, MESSENGER; TH1 CELLS; TH2 CELLS; TRANSCRIPTION, GENETIC; TRANSPLANTATION, HOMOLOGOUS;

EID: 0030480909     PISSN: 09020063     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. WILLIAMS JW, PETERS TG, VERA SR, et al. Biopsy-directed immunosuppression following hepatic transplantation in man. Transplantation 1985: 39: 589.
2. SNOVER DC, FREESE DK, SHARP HL, et al. Liver allograft rejection. An analysis of the use of biopsy in determining outcome of rejection. Am J Surg Pathol 1987: 11(1): 1.
3. KUNTMALM GBG, NERY JR, HUSBERG BS, GONWA TA, TILLERY GW. Rejection in liver transplantation. Hepatology 1989: 6: 978.
4. ADAMS D. Immunological aspects of clinical liver transplantation. Immunol Lett 1991: 29: 69.
5. DOUSSET B, HUBSCHER SG, PADBURY RTA, et al. Acute liver allograft rejection-is treatment always necessary? Transplantation 1993: 55: 529.
6. MOSMANN TR, CHERWLNSKI H, BOND MW, GIEDLIN MA, COFFMAN RL. Two types of murine helper T-cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J Immunol 1986: 136: 2348.
7. ROMAGNANI S. Human Th1 and Th2 subsets: doubt no more. Immunol Today 1991: 12: 256.
8. ROMAGNANI S. Human Th1 and Th2 subsets: Regulation of differentiation and role in protection and immunopathology. Int Arch Allergy 1992: 98: 279.
9. LOWRY RP. The relationship of IL-4, IL-10 and other cytokines to transplantation tolerance. Transplant Sci 1993: 3: 104.
10. DALLMAN MJ. Cytokines as mediators of organ graft rejection and tolerance. Curr Opin Immunol 1993: 5: 788.
11. NICKERSON P, STEURER W, STEIGER J, et al. Cytokines and the Th1/Th2 paradigm in transplantation. Curr Opin Immunol 1994: 6: 757.
12. POWRIE F, COFFMAN RL. Cytokine regulation of T-cell function: potential for therapeutic intervention. Immunol Today 1993: 14: 270.
13. POWRIE F, MENON S, COFFMAN RL. Interleukin-4 and interleukin-10 synergize to inhibit cell-mediated immunity in vivo. Eur J Immunol 1993: 23: 2223.
14. O'GARRA A and MURPHY K. Cytokines in determining T lymphocyte function. Curr Opin Immunol 1994: 6: 458.
15. MARTINEZ OM, KRAMS SM, STERNECK M, et al. Intragraft cytokine profile during human liver allograft rejection. Transplantation 1992: 53: 449.
16. BISHOP GA, ROKAHR KL, NAPOLI J, MCCAUGAN GW. Intragraft cytokine mRNA levels in human liver allograft rejection analyzed by reverse transcription and semiquantitative polymerase chain reaction amplification. Transplant Immunol 1993: 1: 253.
17. COZENZA CA, SHIRWAN H, CRAMER DV, et al. Intragraft cytokine gene expression in human liver allografts. Liver Transplant Surg 1995: 1: 16.
18. BISHOP GA, MATSUMOTO Y, MCCAUGHAN GW, KENNEY JS. Identification of cytokine protein expression in human liver allograft rejection: Methods development and expression of IL-1ß, IL-6, IFN-γ, and basic fibrobfast growth factor. Transpl Proc 1992: 24: 2310.
19. HOFFMANN MW, WONIGEIT K, STEINHOFF G, et al. Production of cytokines (TNF-alpha) and (IL-1-beta) and endothelial cell activation in human liver allograft rejection. Transplantation 1993: 55: 329.
20. BAAN CC, van EMMERIK NEM, BALK AHMM, et al. Cytokine mRNA expression in endomyocardial biopsies during acute rejection from human heart transplants. Clin Exp Immunol 1994: 97: 293.
21. CHOMZYNSKI P, SACCHI N. Single step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987: 162: 156.
22. FARCES O, MORRIS PJ, DALLMANN MJ. Spontaneous acceptance of liver allografts in the rat. Analysis of the immune response. Transplantation 1994: 57: 171.
23. KRAUS Th, NORONHA M, MANNER M, et al. Clinical value of cytokine determination for screening, differentiation, and therapy monitoring of infectious and noninfectious complications after orthotopic liver transplantation. Transpl Proc 1991: 23: 1509.
24. HRICIK DE, ALMAWI WY, STROM TB. Trends in the use of glucocorticoids in renal transplantation. Overview. Transplantation 1994: 57:979.
25. NICKERSON PW, PACHECO A, O'CONNELL PJ, et al. Analysis of cytokine transcripts in pancreatic islet cell allografts during rejection and tolerance induction. Transpl Proc 1993: 25: 984.
26. DALLMAN MJ, ROAKE J, HUGHES D, TOOGOOD G, MORRIS PJ. Sequential analysis of IL-2 gene transcription in renal transplants. Transplantation 1992: 53: 683.
27. COSMAN D. Control of messenger RNA stability. Immunol Today 1987: 8: 16.
28. EGAWA H, MARTINEZ OM, QUINN MB, et al. Characterization of cytokine expression in an animal model of acute liver allograft rejection. Transpl Proc 1995: 27: 505.
29. FARCES O, MORRIS PJ, and DALLMAN MJ. Spontaneous acceptance of rat liver allografts is associated with an early downregulation of intragraft interleukin-4 messenger RNA expression. Hepatology 1995: 21: 767.
30. SUN J, MCCAUGHAN GW, MATSUMOTO Y, et al. Tolerance to rat liver allografts. I. Differences between tolerance and rejection are more marked in the B cell compared with the T cell or cytokine response. Transplantation 1994: 57: 1349.
31. THAI NL, FUMIN F, QIAN S, et al. Cytokine mRNA profiles in mouse orthotopic liver transplantation. Graft rejection is associated with augmented TH1 function. Transplantation 1995: 59: 274.
32. EGAWA H, MARTINEZ OM, QUINN MB, et al. Long-term nonresponsiveness to a liver allograft may be cytokine mediated. Transpl Proc 1995: 27: 241.
33. BUGEON L, CUTERI MC, HALLET MM, et al. Peripheral tolerance of - an allograft in adult rats. Characterization by low interleukin-2 and interferon-γ mRNA levels and by strong accumulation of major histocompatibility complex transcripts in the graft. Transplantation 1992: 54: 219.
34. TAKEUCHI T, LOWRY RP, KONIECZNY B. Heart allografts in murine system. The differential activation of Th2-like effector cells in peripheral tolerance. Transplantation 1992: 53: 1281.
35. KUSAKA S, GRAILER AP, FECHNER Jr. JH, BURLINGHAM WJ. Evidence for a possible TH2 bias in human renal transplant tolerance. Transpl Proc 1995: 27: 225.
36. STARZL TE, DEMETRIS AJ, TRUCCO M, et al. Cell migration and chimerism after whole organ transplantation: the basis of graft acceptance. Hepatology 1993: 17: 1127.
37. STARZL TE, DEMETRIS AJ, TRUCCO M, et al. Systemic chimerism in human female recipients of male livers. Lancet 1992: 340: 876.